Induced Pluripotent Stem Cells (iPSCs) Market Size, Share, Growth, and Industry Analysis, By Types (Human iPSCs,,Mouse iPSCs), By Applications (Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others) , and Regional Insights and Forecast to 2035

1 Study Coverage
1.1 Induced Pluripotent Stem Cells (iPSCs) Product Introduction
1.2 Market by Type
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Human iPSCs
1.2.3 Mouse iPSCs
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Estimates and Forecasts
2.2 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2023 Versus 2030
2.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Region: 2019-2024
2.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Region (2025-2030)
2.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Region (2019-2030)
3 Global Induced Pluripotent Stem Cells (iPSCs) by Company
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Company (2019-2024)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Induced Pluripotent Stem Cells (iPSCs) Companies around the World: Ranking by Revenue
3.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Induced Pluripotent Stem Cells (iPSCs) Companies Headquarters & Product Type
3.4.1 Induced Pluripotent Stem Cells (iPSCs) Companies Headquarters
3.4.2 Global Induced Pluripotent Stem Cells (iPSCs) Companies Product & Service
3.4.3 Date of International Companies Enter into Induced Pluripotent Stem Cells (iPSCs) Market
3.5 Global Induced Pluripotent Stem Cells (iPSCs) Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Fujifilm Holding Corporation (CDI)
4.1.1 Fujifilm Holding Corporation (CDI) Company Information
4.1.2 Fujifilm Holding Corporation (CDI) Description, Business Overview
4.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.1.6 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.1.7 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.1.8 Fujifilm Holding Corporation (CDI) Recent Developments
4.2 Ncardia
4.2.1 Ncardia Company Information
4.2.2 Ncardia Description, Business Overview
4.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.2.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.2.6 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.2.7 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.2.8 Ncardia Recent Developments
4.3 Sumitomo Dainippon Pharma
4.3.1 Sumitomo Dainippon Pharma Company Information
4.3.2 Sumitomo Dainippon Pharma Description, Business Overview
4.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.3.5 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.3.6 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.3.7 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.3.8 Sumitomo Dainippon Pharma Recent Developments
4.4 Astellas Pharma Inc
4.4.1 Astellas Pharma Inc Company Information
4.4.2 Astellas Pharma Inc Description, Business Overview
4.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.4.5 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.4.6 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.4.7 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.4.8 Astellas Pharma Inc Recent Developments
4.5 Fate Therapeutics, Inc
4.5.1 Fate Therapeutics, Inc Company Information
4.5.2 Fate Therapeutics, Inc Description, Business Overview
4.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.5.5 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.5.6 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.5.7 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.5.8 Fate Therapeutics, Inc Recent Developments
4.6 Pluricell Biotech
4.6.1 Pluricell Biotech Company Information
4.6.2 Pluricell Biotech Description, Business Overview
4.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.6.5 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.6.6 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.6.7 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.6.8 Pluricell Biotech Recent Development
4.7 Cell Inspire Biotechnology
4.7.1 Cell Inspire Biotechnology Company Information
4.7.2 Cell Inspire Biotechnology Description, Business Overview
4.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.7.5 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.7.6 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.7.7 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.7.8 Cell Inspire Biotechnology Recent Development
4.8 ReproCELL
4.8.1 ReproCELL Company Information
4.8.2 ReproCELL Description, Business Overview
4.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Products Offered
4.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2019-2024)
4.8.5 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2023
4.8.6 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2023
4.8.7 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2023
4.8.8 ReproCELL Recent Development
5 Breakdown Data by Type
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2019-2024)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2025-2030)
5.3 Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2019-2024)
6.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2025-2030)
6.3 Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2019-2030
7.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2019-2030)
7.3 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2019-2024)
7.4 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2019-2024)
8.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2019-2024)
9 Europe
9.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2019-2030
9.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2019-2030)
9.3 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2019-2024)
9.4 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2019-2030
10.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2019-2030)
10.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2019-2024)
10.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2019-2024)
11.4 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Induced Pluripotent Stem Cells (iPSCs) Supply Chain Analysis
12.2 Induced Pluripotent Stem Cells (iPSCs) Key Raw Materials and Upstream Suppliers
12.3 Induced Pluripotent Stem Cells (iPSCs) Clients Analysis
12.4 Induced Pluripotent Stem Cells (iPSCs) Sales Channel and Sales Model Analysis
12.4.1 Induced Pluripotent Stem Cells (iPSCs) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Induced Pluripotent Stem Cells (iPSCs) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Induced Pluripotent Stem Cells (iPSCs) Distributors
13 Market Dynamics
13.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
13.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers
13.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges
13.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer